Nuvation Bio Inc.

NUVB·NYSE·Healthcare
Compare
4.7300+0.0400 (+0.85%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market4.5400−0.1900 (−4.02%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.6900
Open4.7000
Day range4.52004.7500
52-week range4.04509.7500
Off day high−0.42%
Off 52-week high−51.49%
Volume8.37M
Avg. volume (3M)5.38M
Market cap1.66B
EPS (TTM)-0.4400
Forward P/E-315.33
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.73
Shares outstanding350.12M
Short interest29.65% of float
Earnings dateNov 4, 2026
Analyst target13.0000
Profit margin−88.19%

Against its peers

Compare in full ›
NUVB NVCT AKTS BHVN SNDX TNGX
Market cap 1.66B 602.94M 845.42M 2.30B 940.80M 3.91B
P/E (TTM) — — — — — —
Forward P/E -315.3 -19.2 -7.1 -8.2 -14.4 -13.8
Price/book 5.4 5.1 1.7 -23.4 -54.7 3.8
Dividend yield — — — — — —
1-year change −5.78% +225.75% −32.14% +78.66% −28.86% +189.39%
Today +0.85% −4.50% +1.74% −2.37% −26.87% +0.04%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Nuvation Bio's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Nuvectis Pharma, Inc.NVCT · Biotechnology 602.94M 18.47 −4.50%
Aktis Oncology, Inc.AKTS · Biotechnology 845.42M 15.20 +1.74%
Biohaven Ltd.BHVN · Biotechnology 2.30B 15.24 −2.37%
Syndax Pharmaceuticals, Inc.SNDX · Biotechnology 940.80M 10.45 −26.87%
Tango Therapeutics, Inc.TNGX · Biotechnology 3.91B 23.18 +0.04%
Nuvalent IncNUVL · Biotechnology 9.81B 123.96 0.00%
ArriVent BioPharma, Inc.AVBP · Biotechnology 665.16M 13.49 +3.61%
Nektar TherapeuticsNKTR · Biotechnology 1.31B 38.48 +1.91%

Also based in New York, New York, then elsewhere in New York.

Company Mkt cap Price Today
Citigroup Inc.C · New York, NYOdds 206.47B 124.74 +1.65%
Coinbase Global, Inc.COIN.BA · New York, NY 67.45T 9,435.00 +4.43%
The Bank of New York Mellon CorporationBNY.BA · New York, NY 43.07T 128,000.00 +2.58%
Verizon Communications Inc.VZ · New York, NYOdds 191.36B 46.17 +2.06%
Pfizer Inc.PFE · New York, NYOdds 175.50B 30.79 +2.63%
JPMorgan Chase & Co.JPM · New York, NYOdds 935.06B 352.11 +4.18%
Colgate-Palmolive CompanyCL.BA · New York, NY 14.28T 53,900.00 +1.60%
Morgan StanleyMS · New York, NYOdds 303.56B 193.97 +4.23%

The stocks whose daily moves over the past year went most closely with Nuvation Bio's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Taysha Gene Therapies, Inc.TSHA · Correlation 0.36 1.42B 4.3600 +6.60%
Annexon, Inc.ANNX · Correlation 0.35 820.88M 4.3300 +3.34%
Generate Biomedicines, Inc.GENB · Correlation 0.35 1.82B 14.16 +2.24%
Immunocore Holdings plcIMCR · Correlation 0.35 1.51B 29.23 −2.66%
Stoke Therapeutics, Inc.STOK · Correlation 0.34 1.78B 27.45 +1.70%
Intellia Therapeutics, Inc.NTLA · Correlation 0.33 1.72B 12.31 +3.79%
Lyell Immunopharma, Inc.LYEL · Correlation 0.32 378.11M 15.43 +43.27%

What visitors to Nuvation Bio's page also look at.

Company Mkt cap Price Today
Lyell Immunopharma, Inc.LYEL 378.11M 15.43 +43.27%
Taysha Gene Therapies, Inc.TSHA 1.42B 4.3600 +6.60%
Stoke Therapeutics, Inc.STOK 1.78B 27.45 +1.70%
Olema Pharmaceuticals, Inc.OLMA 659.73M 7.54 +2.59%
Annexon, Inc.ANNX 820.88M 4.3300 +3.34%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NUVB news ›
Markets Daily·Negative

Nuvation Bio (NYSE:NUVB) Announces Earnings Results

Nuvation Bio (NYSE:NUVB – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.12) EPS for the quarter, meeting analysts’ consensus estimates of ($0.12), FiscalAI reports. Nuvation Bio had a…

NUVBNUNAUT
Clinical Trials Arena·Positive

Nuvation Bio to broaden Phase III glioma trial into Europe

Nuvation Bio is to expand its pivotal Phase III SIGMA trial into Europe to evaluate the investigational, oral, brain-penetrant, selective mutant isocitrate dehydrogenase 1 (IDH1) inhibitor safusidenib in patients with IDH1-mutant glioma.…

BLRXNUVB
AOL.com··2 outletsPositive

Nuvation Bio to Expand Pivotal Phase 3 SIGMA Study of Safusidenib for IDH1-Mutant Glioma to Six European Countries

New sites in the UK, France, Sweden, Germany, Italy and Spain will add to the global footprint of the pivotal SIGMA study Study site locations will be listed on ClinicalTrials.gov and updated as finalized. In August 2026, the FDA granted…

SPCXBLRX
More from 1 other outlet

From the 4Search news index, newest first.

In the news

14mentions in 30 days
14with it in the headline
Positivesentiment

Mentioned with

Citigroup10NU Holdings7NU Holdings Ltd.7Nubank6Nuvation Bio Inc6Biogen5Chart Nuvation Bio Inc5JPMorgan4

People in the coverage

Baker Hughes11Danessa Lincoln11Fintel Fintel8George Maybach8Sarita Garza5Mitch Edgeman4

Themes

Healthcare5Earnings4Financial4Biotechnology3Results3Cancer2Data2EPS2

Most coverage from

  1. marketscreener.com8
  2. prnewswire.com3
  3. themarketsdaily.com2
  4. aol.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance